| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/05/2012 | WO2012002680A2 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors |
| 01/05/2012 | WO2012002644A2 Sustained-release pharmaceutical composition containing pramipexole or pharmaceutically acceptable salt thereof with improved stability |
| 01/05/2012 | WO2012002640A2 Transdermal drug delivery system containing donepezil |
| 01/05/2012 | WO2012002583A1 Method for treating schizophrenia and related diseases with a combination therapy |
| 01/05/2012 | WO2012002577A1 Novel nicotinamide derivatives or salts thereof |
| 01/05/2012 | WO2012002568A1 Azaindole derivative |
| 01/05/2012 | WO2012002547A1 Bosentan solid dispersion |
| 01/05/2012 | WO2012002539A1 Novel noncrystalline bosentan and process for preparation thereof |
| 01/05/2012 | WO2012002536A1 Vegf production promoter |
| 01/05/2012 | WO2012002527A1 HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR |
| 01/05/2012 | WO2012002502A1 Dihydropyrimidinone derivative and pharmaceutical use thereof |
| 01/05/2012 | WO2012002464A1 ω3 FATTY ACID COMPOUND PREPARATION |
| 01/05/2012 | WO2012002379A1 Fish parasite extermination agent and extermination method |
| 01/05/2012 | WO2012002328A1 Blood hdl level increasing agent or anti-arteriosclerotic agent |
| 01/05/2012 | WO2012002322A1 Skin properties improving agent for oral administration |
| 01/05/2012 | WO2012001941A1 Prophylactic or ameliorating agent for genetic diseases |
| 01/05/2012 | WO2012001695A1 A process for etra virine intermediate and polymorphs of etravirine |
| 01/05/2012 | WO2012001673A1 Amorphous form of dronedarone |
| 01/05/2012 | WO2012001641A1 Stable pharmaceutical compositions |
| 01/05/2012 | WO2012001525A2 Intelligent gate drive |
| 01/05/2012 | WO2012001494A2 Pharmaceutical compositions comprising paracetamol and process for preparing the same |
| 01/05/2012 | WO2012001438A1 Use of kynurenic acid amide derivatives for the treatment of huntington's disease |
| 01/05/2012 | WO2012001418A1 Multi-metallic complexes |
| 01/05/2012 | WO2012001411A2 Formulations and delivery |
| 01/05/2012 | WO2012001403A1 Topical pharmaceutical composition comprising flurbiprofen |
| 01/05/2012 | WO2012001357A1 Crystalline form of prulifloxacin and processes for its preparation |
| 01/05/2012 | WO2012001338A1 Composition for the treatment of acne vulgaris |
| 01/05/2012 | WO2012001336A1 Treatment of cognitive disorders |
| 01/05/2012 | WO2012001308A1 Method for synthesizing ergoline alkaloids from indolic bicyclic compounds by double cyclization, resulting materials, and intermediate materials |
| 01/05/2012 | WO2012001194A1 Cation derivatives of 2,7,12,17-aryl porphycenes, preparation method thereof and use of same as photosensitisers in antimicrobial photodynamic therapy |
| 01/05/2012 | WO2012001191A1 Method for diagnosing farber's disease |
| 01/05/2012 | WO2012001151A1 Novel salts as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 01/05/2012 | WO2012001148A1 Novel calcium salts of compound as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 01/05/2012 | WO2012001121A1 Calpain-3 inhibitors for treating muscular dystrophies and cardiomyopathies |
| 01/05/2012 | WO2012001093A2 Liquid formulations of rupatadine fumarate |
| 01/05/2012 | WO2012001089A1 Antibiotic compositions |
| 01/05/2012 | WO2012001083A2 Novel eprinomectin injectable compositions |
| 01/05/2012 | WO2012001076A1 Use of squaramide in the prevention and/or treatment of rosacea |
| 01/05/2012 | WO2012001074A2 Pharmaceutical compositions comprising 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactate monohydrate. |
| 01/05/2012 | WO2012001065A2 Method for preventing or treating skin tumor |
| 01/05/2012 | WO2012001064A2 Method for preventing or treating skin tumor |
| 01/05/2012 | WO2012001055A1 Metronidazole esters for treating rosacea |
| 01/05/2012 | WO2012001054A1 Metronidazole esters for treating rosacea |
| 01/05/2012 | WO2012001053A1 Metronidazole esters for treating rosacea |
| 01/05/2012 | WO2012001028A1 Antimicrobial combinations of pyrion compounds with polyethyleneimines |
| 01/05/2012 | WO2012001020A1 Novel tetrahydroquinoline derivatives |
| 01/05/2012 | WO2012001009A1 Polymeric system for delivering a preservative-free prostaglandin-based nonviscous solution |
| 01/05/2012 | WO2012000981A1 Pharmaceutical composition comprising drospirenone and contraceptive kit |
| 01/05/2012 | WO2012000970A1 Triazolopyridines as tyk2 inhibitors |
| 01/05/2012 | WO2012000945A1 Substituted dicyanopyridines and use thereof |
| 01/05/2012 | WO2012000933A1 3-amino-5,6-dihydro-1h-pyrazin-2-one derivatives useful for the treatement of alzheimer's disease and other forms of dementia |
| 01/05/2012 | WO2012000926A1 Silodosin-cyclodextrin inclusion compounds |
| 01/05/2012 | WO2012000909A1 Once-a-month method of contraception |
| 01/05/2012 | WO2012000904A1 Pharmaceutical composition for use in the treatment of glaucoma |
| 01/05/2012 | WO2012000899A1 Semuloparin for use as an antithrombotic treatment in orthopaedic surgery with improved benefit-risk profile |
| 01/05/2012 | WO2012000889A1 Aptamers that inhibit interaction between antibody and 2nd extracellular loop of human beta-1-adrenergic receptor |
| 01/05/2012 | WO2012000881A1 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/05/2012 | WO2012000861A1 11c-labelled aptamer for detecting a diseased tissue |
| 01/05/2012 | WO2012000667A1 Axomadol or metabolite thereof for use in the treatment of irritable bowel syndrome |
| 01/05/2012 | WO2012000666A1 Tapentadol for use in the treatment of irritable bowel syndrome |
| 01/05/2012 | WO2012000634A1 Pharmaceutical composition for the treatment of erectile dysfunction |
| 01/05/2012 | WO2012000632A1 Pyrazolo-quinolines |
| 01/05/2012 | WO2012000595A1 2,4- diaryl - substituted [1,8] naphthyridines as kinase inhibitors for use against cancer |
| 01/05/2012 | WO2012000519A1 Aryl- and heteroarylamid derivatives as pde10a enzyme inhibitor |
| 01/05/2012 | WO2012000499A1 New polymorphic form of a calcimimetic compound |
| 01/05/2012 | WO2012000498A1 New polymorphic form of a calcimimetic compound |
| 01/05/2012 | WO2012000443A1 Recombinant tumor vaccine and method of producing such vaccine |
| 01/05/2012 | WO2012000421A1 Uses of gossypol derivatives in manufacture of antitumor medicaments |
| 01/05/2012 | WO2012000377A1 Pharmaceutical composition comprising levocarnitine and dobesilate |
| 01/05/2012 | WO2012000356A1 Quinazoline compounds |
| 01/05/2012 | WO2012000322A1 Peptide deformylase inhibitors containing 4-methylene pyrrolidine |
| 01/05/2012 | WO2012000306A1 Phenyl nitrone compounds containing stilbene segment and use thereof |
| 01/05/2012 | WO2012000304A1 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof |
| 01/05/2012 | WO2012000253A1 Composition for injection comprising docetaxel and preparation method thereof |
| 01/05/2012 | WO2012000212A1 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof |
| 01/05/2012 | WO2012000182A1 Quinazoline compounds |
| 01/05/2012 | WO2012000104A1 Non-liposomal systems for nucleic acid delivery |
| 01/05/2012 | WO2012000103A1 Methods of targeting pten mutant diseases and compositions therefor |
| 01/05/2012 | WO2012000087A1 Compositions and methods for controlling blood glucose levels |
| 01/05/2012 | WO2012000082A1 Use of leukotriene b4 in combination with a toll-like receptor ligand, a rig-l-like receptor ligand or a nod-like receptor ligand to enhance the innate immune response |
| 01/05/2012 | WO2012000055A1 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease |
| 01/05/2012 | WO2012000048A1 A reconstituted high density lipoprotein formulation and production method thereof |
| 01/05/2012 | WO2012000036A1 Treatment of abnormalities of glucose metabolism with an antagonist of inhibitor of differentiation 1 |
| 01/05/2012 | WO2011142782A9 Zone compensated multilayer laue lens and apparatus and method of fabricating the same |
| 01/05/2012 | WO2011141933A3 Process for preparation of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid and its pharmaceutically acceptable salts |
| 01/05/2012 | WO2011141113A3 Combination of vitamin k and nicotinamide |
| 01/05/2012 | WO2011140595A3 Immunostimulatory and vaccine compositions |
| 01/05/2012 | WO2011140226A3 Compositions comprising extracts of southernwood and an amine compound |
| 01/05/2012 | WO2011133227A3 Synthetic oligosaccharides for staphyloccocus vaccine |
| 01/05/2012 | WO2011131947A3 A process for particle processing of active pharmaceutical ingredients |
| 01/05/2012 | WO2011130707A9 Compounds, compositions, and methods for reducing or eliminating bitter taste |
| 01/05/2012 | WO2011130302A3 Method of treating obesity using antioxidant inflammation modulators |
| 01/05/2012 | WO2011130194A3 Methods for producing viloxazine salts and novel polymorphs thereof |
| 01/05/2012 | WO2011126853A9 Prevention or delay of onset of oral mucositis |
| 01/05/2012 | WO2011126852A9 Treatment of gout |
| 01/05/2012 | WO2011125040A3 New polyterpene type compounds, compositions containing them and topical uses thereof |
| 01/05/2012 | WO2011115998A3 Modulators of hec1 activity and methods therefor |
| 01/05/2012 | WO2011115819A3 Small molecule inhibitors of muc1 and methods of identifying the same |
| 01/05/2012 | WO2011112558A3 Solid compositions |
| 01/05/2012 | WO2011112428A3 Arylvinylazacycloalkane compounds for constipation |